Spectral AI Receives UKCA Mark and FDA Class 1 Medical Device Classification for DeepView SnapShot Wound Imaging System

DENVER, Colo., Oct 19, 2023 ( Spectral AI, Inc. (NASDAQ: MDAI) stated, this morning, that its DeepView SnapShot® Wound Imaging System was UK Conformity Assessed (UKCA)-marked for use in the United Kingdom and has received Class 1 medical device classification with the United States Food and Drug Administration (FDA).

Spectral AI is trading at $2.95, up $0.36 (+13.90%), on 315.2K premarket shares traded.

Its 52-week range is $2.20 to $19.50. $4 is its key inflection point, after that there’s a little resistance in the mid-$4 range and a lot of room to run much high, if it picks up massive volume.

 24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to or for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist